August 1, 2024

Petoskey man is first in state to receive HEMGENIX gene therapy — 9&10 News

GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.

Read full story on 9&10 News

Recent Posts

From Bleeds to Birdies with Golf Pro Perry Parker

Today on Beyond the Bleeds, Heather and John welcome Perry Parker, professional golfer and passionate advocate for the bleeding disorder community. We dive into Perry’s journey from childhood hemophilia diagnosis to his career as a touring golf professional,...

Social Media